Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of Iodixanol Injection safety and effectiveness in CT-enhanced imaging
ChiCTR2000040595Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iodixanol in conditions requiring computed tomography with contrast, sponsored by Beijing Hospital. Primary endpoints: Incidence of adverse reactions and Contrast-induced acute kidney injury (CI-AKI). Planned start Dec 2020; status: not yet recruiting.
02
Drugs
iodixanol
03
Conditions
conditions requiring computed tomography with contrast
Beyond the preview
Go deeper on ChiCTR2000040595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040595.